(+)-alpha-viniferin multiple interactions ISO RGD:10815 6480464 alpha-viniferin inhibits the reaction [IRF1 protein results in increased expression of CXCL10 mRNA], alpha-viniferin inhibits the reaction [IRF1 protein results in increased expression of CXCL10 protein] CTD PMID:20424383 (-)-demecolcine increases expression ISO RGD:735989 6480464 Demecolcine results in increased expression of IRF1 mRNA CTD PMID:23649840 (R)-lipoic acid multiple interactions ISO RGD:735989 6480464 Thioctic Acid results in increased sumoylation of and results in decreased activity of IRF1 protein CTD PMID:24975507 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression EXP 6480464 o, p'-DDT affects the expression of IRF1 mRNA CTD PMID:17984292 1,2-dimethylhydrazine multiple interactions ISO RGD:10815 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IRF1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine affects expression ISO RGD:10815 6480464 1, 2-Dimethylhydrazine affects the expression of IRF1 mRNA CTD PMID:22206623 1,4-benzoquinone multiple interactions ISO RGD:735989 6480464 quinone promotes the reaction [IFNG protein results in increased expression of IRF1 mRNA] CTD PMID:31248982 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:735989 6480464 Dinitrochlorobenzene results in increased expression of IRF1 mRNA CTD PMID:20146380 1-nitropyrene increases expression ISO RGD:735989 6480464 1-nitropyrene results in increased expression of IRF1 mRNA CTD PMID:21540303 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:10815 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased expression of IRF1 mRNA] CTD PMID:12847270 17beta-estradiol multiple interactions ISO RGD:735989 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of IRF1 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO RGD:735989 6480464 Estradiol results in increased expression of IRF1 mRNA CTD PMID:31614463 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:10815 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10815 6480464 Tetrachlorodibenzodioxin affects the expression of IRF1 mRNA CTD PMID:21570461 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735989 6480464 Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA CTD PMID:19684285 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IRF1 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10815 6480464 Tetrachlorodibenzodioxin results in increased expression of IRF1 mRNA CTD PMID:15667827 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735989 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of IRF1 mRNA, [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in increased expression of IRF1 mRNA CTD PMID:14761676 , PMID:29704546 2,4,6-trinitrobenzenesulfonic acid decreases response to substance ISO RGD:10815 6480464 IRF1 protein results in decreased susceptibility to Trinitrobenzenesulfonic Acid CTD PMID:21097874 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:10815 6480464 Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IRF1 mRNA] CTD PMID:20737476 2-bromohexadecanoic acid multiple interactions ISO RGD:735989 6480464 2-bromopalmitate promotes the reaction [Tretinoin results in increased expression of IRF1 mRNA] CTD PMID:30076181 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of IRF1 mRNA CTD PMID:14600272 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:10815 6480464 tetrabromobisphenol A results in decreased expression of IRF1 mRNA CTD PMID:25172293 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:735989 6480464 [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in increased expression of IRF1 mRNA CTD PMID:14761676 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:735989 6480464 4 more ... CTD PMID:31596606 4,4'-sulfonyldiphenol increases methylation ISO RGD:10815 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of IRF1 exon CTD PMID:33297965 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of IRF1 mRNA CTD PMID:21893156 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IRF1 mRNA CTD PMID:14600272 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid multiple interactions ISO RGD:735989 6480464 Am 580 affects the localization of [Am 580 results in increased expression of IRF1 protein] more ... CTD PMID:16085646 , PMID:16636311 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO RGD:735989 6480464 Am 580 results in increased expression of IRF1 protein CTD PMID:16085646 , PMID:16636311 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases activity ISO RGD:735989 6480464 Am 580 results in increased activity of IRF1 protein CTD PMID:16636311 4-hydroxyphenyl retinamide increases expression ISO RGD:735989 6480464 Fenretinide results in increased expression of IRF1 mRNA CTD PMID:15958647 4-hydroxyphenyl retinamide increases expression ISO RGD:10815 6480464 Fenretinide results in increased expression of IRF1 mRNA CTD PMID:28973697 4-tert-Octylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of IRF1 mRNA CTD PMID:17011747 5-aza-2'-deoxycytidine increases expression ISO RGD:735989 6480464 Decitabine results in increased expression of IRF1 mRNA CTD PMID:17785578 9-cis-retinoic acid increases expression ISO RGD:735989 6480464 Alitretinoin results in increased expression of IRF1 more ... CTD PMID:16085646 more ... acetylsalicylic acid increases expression ISO RGD:735989 6480464 Aspirin results in increased expression of IRF1 mRNA CTD PMID:15928584 acrolein increases expression ISO RGD:10815 6480464 Acrolein results in increased expression of IRF1 mRNA CTD PMID:18515264 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of IRF1 mRNA CTD PMID:28959563 actinomycin D multiple interactions ISO RGD:735989 6480464 Dactinomycin inhibits the reaction [Tretinoin promotes the reaction [IFNG protein results in increased expression of IRF1 protein]], Dactinomycin inhibits the reaction [Tretinoin results in increased expression of IRF1 mRNA] CTD PMID:16085646 , PMID:16636311 aldehydo-D-glucosamine multiple interactions ISO RGD:10815 6480464 Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IRF1 mRNA] CTD PMID:20737476 all-trans-retinoic acid multiple interactions ISO RGD:735989 6480464 2-bromopalmitate promotes the reaction [Tretinoin results in increased expression of IRF1 mRNA] more ... CTD PMID:16085646 more ... all-trans-retinoic acid increases expression ISO RGD:735989 6480464 Tretinoin results in increased expression of IRF1 mRNA, Tretinoin results in increased expression of IRF1 protein CTD PMID:15498508 more ... all-trans-retinoic acid increases activity ISO RGD:735989 6480464 Tretinoin results in increased activity of IRF1 protein CTD PMID:16636311 amiodarone increases expression ISO RGD:735989 6480464 Amiodarone results in increased expression of IRF1 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IRF1 mRNA CTD PMID:16483693 antimycin A increases expression ISO RGD:735989 6480464 Antimycin A results in increased expression of IRF1 mRNA CTD PMID:33512557 antirheumatic drug decreases expression ISO RGD:735989 6480464 Antirheumatic Agents results in decreased expression of IRF1 mRNA CTD PMID:24449571 aristolochic acid A multiple interactions ISO RGD:10815 6480464 aristolochic acid I inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IRF1 mRNA], aristolochic acid I inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IRF1 protein] CTD PMID:24412304 aristolochic acid A increases expression ISO RGD:735989 6480464 aristolochic acid I results in increased expression of IRF1 mRNA CTD PMID:33212167 arsane increases methylation ISO RGD:735989 6480464 Arsenic results in increased methylation of IRF1 gene CTD PMID:27838757 arsane decreases expression ISO RGD:735989 6480464 Arsenic results in decreased expression of IRF1 mRNA CTD PMID:27838757 arsenic atom decreases expression ISO RGD:735989 6480464 Arsenic results in decreased expression of IRF1 mRNA CTD PMID:27838757 arsenic atom increases methylation ISO RGD:735989 6480464 Arsenic results in increased methylation of IRF1 gene CTD PMID:27838757 arsenite(3-) increases methylation ISO RGD:735989 6480464 arsenite results in increased methylation of IRF1 promoter CTD PMID:23974009 arsenous acid decreases expression ISO RGD:735989 6480464 Arsenic Trioxide results in decreased expression of IRF1 mRNA CTD PMID:20458559 , PMID:22521957 arsenous acid increases expression ISO RGD:735989 6480464 Arsenic Trioxide results in increased expression of IRF1 mRNA CTD PMID:16914093 , PMID:20953137 arsenous acid multiple interactions ISO RGD:735989 6480464 Arsenic Trioxide promotes the reaction [[IFNG protein results in increased activity of STAT1 protein] which results in increased expression of IRF1 mRNA] more ... CTD PMID:14668793 azathioprine decreases expression ISO RGD:10815 6480464 Azathioprine results in decreased expression of IRF1 mRNA CTD PMID:16473374 benzene decreases expression ISO RGD:10815 6480464 Benzene results in decreased expression of IRF1 mRNA CTD PMID:15120971 benzene increases expression ISO RGD:735989 6480464 Benzene results in increased expression of IRF1 mRNA CTD PMID:33064461 benzo[a]pyrene increases expression ISO RGD:735989 6480464 Benzo(a)pyrene results in increased expression of IRF1 mRNA CTD PMID:20064835 benzo[a]pyrene decreases methylation ISO RGD:735989 6480464 Benzo(a)pyrene results in decreased methylation of IRF1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:735989 6480464 Benzo(a)pyrene affects the methylation of IRF1 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10815 6480464 Benzo(a)pyrene results in increased expression of IRF1 mRNA CTD PMID:23735875 benzo[a]pyrene affects expression ISO RGD:10815 6480464 Benzo(a)pyrene affects the expression of IRF1 mRNA CTD PMID:22342234 beta-D-glucosamine multiple interactions ISO RGD:10815 6480464 Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IRF1 mRNA] CTD PMID:20737476 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IRF1 mRNA CTD PMID:18164116 beta-naphthoflavone decreases expression ISO RGD:735989 6480464 beta-Naphthoflavone results in decreased expression of IRF1 mRNA CTD PMID:32858204 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of IRF1 mRNA CTD PMID:16648578 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IRF1 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:735989 6480464 bisphenol A results in decreased methylation of IRF1 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:735989 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of IRF1 gene CTD PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of IRF1 gene CTD PMID:28505145 bisphenol A decreases expression ISO RGD:735989 6480464 bisphenol A results in decreased expression of IRF1 mRNA CTD PMID:25912373 bisphenol F increases expression ISO RGD:10815 6480464 bisphenol F results in increased expression of IRF1 mRNA CTD PMID:30951980 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of IRF1 mRNA CTD PMID:24136188 cadmium selenide multiple interactions ISO RGD:735989 6480464 [cadmium selenide co-treated with zinc sulfide] results in increased expression of IRF1 mRNA CTD PMID:22342292 calcitriol decreases expression ISO RGD:735989 6480464 Calcitriol results in decreased expression of IRF1 mRNA CTD PMID:16002434 carbon nanotube affects expression ISO RGD:10815 6480464 Nanotubes, Carbon affects the expression of IRF1 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:735989 6480464 CGP 52608 promotes the reaction [RORA protein binds to IRF1 gene] CTD PMID:28238834 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of IRF1 mRNA CTD PMID:23125180 chlorpyrifos increases expression ISO RGD:10815 6480464 Chlorpyrifos results in increased expression of IRF1 mRNA CTD PMID:32715474 chromium(6+) affects expression ISO RGD:10815 6480464 chromium hexavalent ion affects the expression of IRF1 mRNA CTD PMID:28472532 ciglitazone multiple interactions ISO RGD:10815 6480464 ciglitazone inhibits the reaction [IFNG protein results in increased expression of IRF1 mRNA] CTD PMID:12847270 ciguatoxin CTX1B affects expression ISO RGD:10815 6480464 Ciguatoxins affects the expression of IRF1 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:10815 6480464 Cisplatin results in increased expression of IRF1 mRNA CTD PMID:26546572 cisplatin increases expression ISO RGD:735989 6480464 Cisplatin results in increased expression of IRF1 mRNA CTD PMID:27392435 clofibrate decreases expression ISO RGD:10815 6480464 Clofibrate results in decreased expression of IRF1 mRNA CTD PMID:23811191 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of IRF1 mRNA CTD PMID:17602206 crocidolite asbestos decreases expression ISO RGD:10815 6480464 Asbestos, Crocidolite results in decreased expression of IRF1 mRNA CTD PMID:29279043 cyclosporin A increases expression ISO RGD:735989 6480464 Cyclosporine results in increased expression of IRF1 mRNA CTD PMID:20106945 dacarbazine increases expression ISO RGD:735989 6480464 Dacarbazine results in increased expression of IRF1 mRNA CTD PMID:17973783 dacarbazine multiple interactions ISO RGD:735989 6480464 Isotretinoin promotes the reaction [Dacarbazine results in increased expression of IRF1 mRNA] CTD PMID:17973783 dexamethasone increases expression ISO RGD:10815 6480464 Dexamethasone results in increased expression of IRF1 mRNA CTD PMID:21041162 dexamethasone multiple interactions ISO RGD:735989 6480464 4 more ... CTD PMID:31596606 dexamethasone decreases expression ISO RGD:10815 6480464 Dexamethasone results in decreased expression of IRF1 mRNA CTD PMID:22733784 diarsenic trioxide multiple interactions ISO RGD:735989 6480464 Arsenic Trioxide promotes the reaction [[IFNG protein results in increased activity of STAT1 protein] which results in increased expression of IRF1 mRNA] more ... CTD PMID:14668793 diarsenic trioxide increases expression ISO RGD:735989 6480464 Arsenic Trioxide results in increased expression of IRF1 mRNA CTD PMID:16914093 , PMID:20953137 diarsenic trioxide decreases expression ISO RGD:735989 6480464 Arsenic Trioxide results in decreased expression of IRF1 mRNA CTD PMID:20458559 , PMID:22521957 dibutyl phthalate increases expression ISO RGD:10815 6480464 Dibutyl Phthalate results in increased expression of IRF1 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of IRF1 mRNA CTD PMID:21266533 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of IRF1 mRNA CTD PMID:17011747 dimethyl fumarate multiple interactions ISO RGD:735989 6480464 Dimethyl Fumarate inhibits the reaction [IFNG protein results in increased expression of IRF1 mRNA] CTD PMID:30021835 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of IRF1 mRNA CTD PMID:16122865 divanadium pentaoxide affects expression ISO RGD:735989 6480464 vanadium pentoxide affects the expression of IRF1 mRNA CTD PMID:17459161 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of IRF1 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:10815 6480464 epoxiconazole results in increased expression of IRF1 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:735989 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IRF1 mRNA CTD PMID:29432896 ethyl methanesulfonate increases expression ISO RGD:735989 6480464 Ethyl Methanesulfonate results in increased expression of IRF1 mRNA CTD PMID:23649840 fluoranthene multiple interactions ISO RGD:10815 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF1 mRNA CTD PMID:28329830 fluoranthene increases expression ISO RGD:10815 6480464 fluoranthene results in increased expression of IRF1 mRNA CTD PMID:28329830 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of IRF1 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:10815 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IRF1 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:735989 6480464 Formaldehyde results in increased expression of IRF1 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:735989 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of IRF1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of IRF1 mRNA CTD PMID:20124500 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of IRF1 mRNA CTD PMID:22061828 , PMID:33387578 geraniol increases expression ISO RGD:735989 6480464 geraniol results in increased expression of IRF1 mRNA CTD PMID:27683099 GW 1929 multiple interactions ISO RGD:10815 6480464 GW 1929 inhibits the reaction [IFNG protein results in increased expression of IRF1 mRNA] CTD PMID:12847270 hexachlorobenzene decreases expression EXP 6480464 Hexachlorobenzene results in decreased expression of IRF1 mRNA CTD PMID:15159207 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRF1 mRNA CTD PMID:22129741 isotretinoin multiple interactions ISO RGD:735989 6480464 Isotretinoin promotes the reaction [Dacarbazine results in increased expression of IRF1 mRNA] CTD PMID:17973783 leflunomide increases expression ISO RGD:735989 6480464 leflunomide results in increased expression of IRF1 mRNA CTD PMID:28988120 lipoic acid multiple interactions ISO RGD:735989 6480464 Thioctic Acid results in increased sumoylation of and results in decreased activity of IRF1 protein CTD PMID:24975507 lipopolysaccharide multiple interactions ISO RGD:735989 6480464 [S-(1 more ... CTD PMID:11739238 , PMID:35811015 lipopolysaccharide increases expression ISO RGD:10815 6480464 Lipopolysaccharides results in increased expression of IRF1 mRNA CTD PMID:10975854 more ... lipopolysaccharide decreases expression ISO RGD:10815 6480464 Lipopolysaccharides results in decreased expression of IRF1 mRNA CTD PMID:12057914 lipopolysaccharide multiple interactions ISO RGD:10815 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of IRF1 mRNA] more ... CTD PMID:10415056 more ... lipopolysaccharide increases expression ISO RGD:735989 6480464 Lipopolysaccharides results in increased expression of IRF1 mRNA, Lipopolysaccharides results in increased expression of IRF1 protein CTD PMID:11739238 , PMID:35811015 mangiferin decreases expression ISO RGD:10815 6480464 mangiferin results in decreased expression of IRF1 mRNA CTD PMID:15135318 mercury atom affects response to substance ISO RGD:10815 6480464 IRF1 affects the susceptibility to Mercury CTD PMID:22578563 mercury atom multiple interactions ISO RGD:10815 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF1 mRNA more ... CTD PMID:28453771 mercury dichloride multiple interactions ISO RGD:10815 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF1 mRNA more ... CTD PMID:28453771 mercury(0) affects response to substance ISO RGD:10815 6480464 IRF1 affects the susceptibility to Mercury CTD PMID:22578563 mercury(0) multiple interactions ISO RGD:10815 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF1 mRNA more ... CTD PMID:28453771 methotrexate increases expression ISO RGD:735989 6480464 Methotrexate results in increased expression of IRF1 mRNA CTD PMID:21678067 methyl methanesulfonate increases expression ISO RGD:735989 6480464 Methyl Methanesulfonate results in increased expression of IRF1 mRNA CTD PMID:23649840 methylseleninic acid affects expression ISO RGD:735989 6480464 methylselenic acid affects the expression of IRF1 mRNA CTD PMID:14617803 mono(2-ethylhexyl) phthalate increases expression ISO RGD:735989 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of IRF1 mRNA, mono-(2-ethylhexyl)phthalate results in increased expression of IRF1 protein CTD PMID:31351048 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:735989 6480464 IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA], IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 protein] CTD PMID:31351048 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:735989 6480464 N more ... CTD PMID:12756304 N-acetyl-L-cysteine multiple interactions ISO RGD:735989 6480464 Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein] CTD PMID:20525893 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRF1 mRNA CTD PMID:22129741 N-methyl-N-nitrosourea decreases response to substance ISO RGD:10815 6480464 IRF1 protein results in decreased susceptibility to Methylnitrosourea CTD PMID:15240709 N-methyl-N-nitrosourea increases expression ISO RGD:10815 6480464 Methylnitrosourea results in increased expression of IRF1 mRNA CTD PMID:15240709 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of IRF1 mRNA CTD PMID:17412507 N-nitrosodiethylamine increases expression ISO RGD:10815 6480464 Diethylnitrosamine results in increased expression of IRF1 mRNA CTD PMID:18691550 N-nitrosodiethylamine multiple interactions ISO RGD:10815 6480464 IRF1 protein promotes the reaction [Diethylnitrosamine results in increased abundance of Reactive Oxygen Species], MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of IRF1 mRNA] CTD PMID:18691550 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IRF1 mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRF1 mRNA CTD PMID:18164116 , PMID:22129741 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of IRF1 mRNA CTD PMID:14600272 nickel atom increases expression ISO RGD:735989 6480464 Nickel results in increased expression of IRF1 mRNA CTD PMID:25583101 nickel sulfate increases expression ISO RGD:735989 6480464 nickel sulfate results in increased expression of IRF1 mRNA, nickel sulfate results in increased expression of IRF1 protein CTD PMID:20525893 nickel sulfate multiple interactions ISO RGD:735989 6480464 Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein], Puromycin inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein] CTD PMID:20525893 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of IRF1 mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IRF1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of IRF1 mRNA CTD PMID:25729387 p-menthan-3-ol decreases expression ISO RGD:735989 6480464 Menthol results in decreased expression of IRF1 mRNA CTD PMID:26760959 p-tert-Amylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of IRF1 mRNA CTD PMID:17011747 paraquat increases expression ISO RGD:735989 6480464 Paraquat results in increased expression of IRF1 mRNA CTD PMID:34097952 perfluorononanoic acid increases expression ISO RGD:735989 6480464 perfluoro-n-nonanoic acid results in increased expression of IRF1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of IRF1 mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of IRF1 mRNA CTD PMID:19162173 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of IRF1 mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:735989 6480464 Phenobarbital affects the expression of IRF1 mRNA CTD PMID:19159669 pirinixic acid decreases expression ISO RGD:10815 6480464 pirinixic acid results in decreased expression of IRF1 mRNA CTD PMID:17426115 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of IRF1 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of IRF1 mRNA CTD PMID:19162173 progesterone increases expression ISO RGD:10815 6480464 Progesterone results in increased expression of IRF1 mRNA CTD PMID:21549006 puromycin multiple interactions ISO RGD:735989 6480464 Puromycin inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein] CTD PMID:20525893 pyrrolidine dithiocarbamate multiple interactions ISO RGD:735989 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IRF1 protein] CTD PMID:11739238 reactive oxygen species multiple interactions ISO RGD:10815 6480464 IRF1 protein promotes the reaction [Diethylnitrosamine results in increased abundance of Reactive Oxygen Species] CTD PMID:18691550 resveratrol increases expression ISO RGD:10815 6480464 resveratrol analog results in increased expression of IRF1 mRNA CTD PMID:15652768 resveratrol multiple interactions ISO RGD:10815 6480464 Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of IRF1 protein] CTD PMID:35156769 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of IRF1 mRNA CTD PMID:25905778 Ro 41-5253 multiple interactions ISO RGD:735989 6480464 Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of IRF1 protein], Ro 41-5253 inhibits the reaction [Tretinoin results in increased expression of IRF1 protein] CTD PMID:16085646 , PMID:16636311 ruxolitinib multiple interactions ISO RGD:735989 6480464 ruxolitinib inhibits the reaction [IFNB1 protein results in increased expression of IRF1 mRNA] CTD PMID:28365849 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:735989 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IRF1 mRNA CTD PMID:35811015 silicon dioxide increases expression ISO RGD:735989 6480464 Silicon Dioxide analog results in increased expression of IRF1 mRNA, Silicon Dioxide results in increased expression of IRF1 mRNA CTD PMID:23806026 , PMID:25351596 silver atom decreases expression ISO RGD:735989 6480464 Silver results in decreased expression of IRF1 mRNA CTD PMID:22342292 silver atom increases expression ISO RGD:10815 6480464 Silver results in increased expression of IRF1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:735989 6480464 Silver results in decreased expression of IRF1 mRNA CTD PMID:22342292 silver(0) increases expression ISO RGD:10815 6480464 Silver results in increased expression of IRF1 mRNA CTD PMID:27131904 simvastatin multiple interactions ISO RGD:10815 6480464 Simvastatin inhibits the reaction [IFNG results in increased expression of IRF1 mRNA] CTD PMID:17507688 sodium arsenite increases expression ISO RGD:10815 6480464 sodium arsenite results in increased expression of IRF1 mRNA CTD PMID:36209798 sotorasib multiple interactions ISO RGD:735989 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IRF1 mRNA CTD PMID:36139627 SR 144528 multiple interactions ISO RGD:735989 6480464 SR 144528 inhibits the reaction [caryophyllene inhibits the reaction [TNF protein results in increased expression of IRF1 protein]] CTD PMID:28624443 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of IRF1 mRNA CTD PMID:25905778 sunitinib decreases expression ISO RGD:735989 6480464 Sunitinib results in decreased expression of IRF1 mRNA CTD PMID:31533062 tamibarotene increases expression ISO RGD:735989 6480464 tamibarotene results in increased expression of IRF1 mRNA CTD PMID:15498508 , PMID:17229644 tamoxifen affects expression ISO RGD:10815 6480464 Tamoxifen affects the expression of IRF1 mRNA CTD PMID:20937368 tebufenpyrad increases expression ISO RGD:735989 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of IRF1 mRNA CTD PMID:33512557 temozolomide increases expression ISO RGD:735989 6480464 Temozolomide results in increased expression of IRF1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:10815 6480464 tert-Butylhydroperoxide results in increased expression of IRF1 mRNA CTD PMID:15003993 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of IRF1 mRNA CTD PMID:12734012 thifluzamide increases expression ISO RGD:735989 6480464 thifluzamide results in increased expression of IRF1 mRNA CTD PMID:33512557 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IRF1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:735989 6480464 titanium dioxide results in increased expression of IRF1 mRNA CTD PMID:22342292 titanium dioxide decreases expression ISO RGD:10815 6480464 titanium dioxide results in decreased expression of IRF1 mRNA CTD PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IRF1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of IRF1 mRNA CTD PMID:25729387 trametinib multiple interactions ISO RGD:735989 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IRF1 mRNA CTD PMID:36139627 Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of IRF1 mRNA CTD PMID:17553608 trichostatin A affects expression ISO RGD:735989 6480464 trichostatin A affects the expression of IRF1 mRNA CTD PMID:28542535 triclosan increases expression ISO RGD:735989 6480464 Triclosan results in increased expression of IRF1 mRNA CTD PMID:30510588 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of IRF1 mRNA CTD PMID:21893156 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of IRF1 mRNA CTD PMID:30589522 triptonide affects expression ISO RGD:10815 6480464 triptonide affects the expression of IRF1 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:735989 6480464 troglitazone results in increased expression of IRF1 mRNA CTD PMID:19140230 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of IRF1 mRNA CTD PMID:24136188 trovafloxacin multiple interactions ISO RGD:10815 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IRF1 mRNA CTD PMID:18930950 tunicamycin increases expression ISO RGD:735989 6480464 Tunicamycin results in increased expression of IRF1 mRNA CTD PMID:29453283 valproic acid increases expression ISO RGD:10815 6480464 Valproic Acid results in increased expression of IRF1 mRNA CTD PMID:19136453 valproic acid affects expression ISO RGD:735989 6480464 Valproic Acid affects the expression of IRF1 mRNA CTD PMID:25979313 vanadium atom increases activity ISO RGD:735989 6480464 Vanadium results in increased activity of IRF1 protein CTD PMID:19000753 vanadium(0) increases activity ISO RGD:735989 6480464 Vanadium results in increased activity of IRF1 protein CTD PMID:19000753 vancomycin decreases expression ISO RGD:10815 6480464 Vancomycin results in decreased expression of IRF1 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of IRF1 mRNA CTD PMID:23034163 vincristine increases expression ISO RGD:735989 6480464 Vincristine results in increased expression of IRF1 mRNA CTD PMID:23649840 zinc atom multiple interactions ISO RGD:735989 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of IRF1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:735989 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of IRF1 mRNA CTD PMID:18593933